img

Global Transthyretin Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transthyretin Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Transthyretin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Transthyretin is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Transthyretin is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Transthyretin is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc and Regeneron Pharmaceuticals Inc, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Transthyretin, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Transthyretin by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Transthyretin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Transthyretin market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
By Type
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
By Application
Familial Amyloid Neuropathies
Alzheimer's Disease
Cardomyopathy
Neuropathy
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Transthyretin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Transthyretin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transthyretin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Transthyretin Definition
1.2 Market by Type
1.2.1 Global Transthyretin Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AG-10
1.2.3 ALN-TTRsc02
1.2.4 CRX-1008
1.2.5 EDE-1307
1.2.6 Inotersen Sodium
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Transthyretin Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Familial Amyloid Neuropathies
1.3.3 Alzheimer's Disease
1.3.4 Cardomyopathy
1.3.5 Neuropathy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Transthyretin Sales
2.1 Global Transthyretin Revenue Estimates and Forecasts 2018-2034
2.2 Global Transthyretin Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Transthyretin Revenue by Region
2.3.1 Global Transthyretin Revenue by Region (2018-2023)
2.3.2 Global Transthyretin Revenue by Region (2024-2034)
2.4 Global Transthyretin Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Transthyretin Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Transthyretin Sales Quantity by Region
2.6.1 Global Transthyretin Sales Quantity by Region (2018-2023)
2.6.2 Global Transthyretin Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Transthyretin Sales Quantity by Manufacturers
3.1.1 Global Transthyretin Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Transthyretin Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Transthyretin Sales in 2024
3.2 Global Transthyretin Revenue by Manufacturers
3.2.1 Global Transthyretin Revenue by Manufacturers (2018-2023)
3.2.2 Global Transthyretin Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Transthyretin Revenue in 2024
3.3 Global Transthyretin Sales Price by Manufacturers
3.4 Global Key Players of Transthyretin, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Transthyretin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Transthyretin, Product Offered and Application
3.8 Global Key Manufacturers of Transthyretin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Transthyretin Sales Quantity by Type
4.1.1 Global Transthyretin Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Transthyretin Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Transthyretin Sales Quantity Market Share by Type (2018-2034)
4.2 Global Transthyretin Revenue by Type
4.2.1 Global Transthyretin Historical Revenue by Type (2018-2023)
4.2.2 Global Transthyretin Forecasted Revenue by Type (2024-2034)
4.2.3 Global Transthyretin Revenue Market Share by Type (2018-2034)
4.3 Global Transthyretin Price by Type
4.3.1 Global Transthyretin Price by Type (2018-2023)
4.3.2 Global Transthyretin Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Transthyretin Sales Quantity by Application
5.1.1 Global Transthyretin Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Transthyretin Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Transthyretin Sales Quantity Market Share by Application (2018-2034)
5.2 Global Transthyretin Revenue by Application
5.2.1 Global Transthyretin Historical Revenue by Application (2018-2023)
5.2.2 Global Transthyretin Forecasted Revenue by Application (2024-2034)
5.2.3 Global Transthyretin Revenue Market Share by Application (2018-2034)
5.3 Global Transthyretin Price by Application
5.3.1 Global Transthyretin Price by Application (2018-2023)
5.3.2 Global Transthyretin Price Forecast by Application (2024-2034)
6 North America
6.1 North America Transthyretin Sales by Company
6.1.1 North America Transthyretin Revenue by Company (2018-2023)
6.1.2 North America Transthyretin Sales Quantity by Company (2018-2023)
6.2 North America Transthyretin Market Size by Type
6.2.1 North America Transthyretin Sales Quantity by Type (2018-2034)
6.2.2 North America Transthyretin Revenue by Type (2018-2034)
6.3 North America Transthyretin Market Size by Application
6.3.1 North America Transthyretin Sales Quantity by Application (2018-2034)
6.3.2 North America Transthyretin Revenue by Application (2018-2034)
6.4 North America Transthyretin Market Size by Country
6.4.1 North America Transthyretin Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Transthyretin Revenue by Country (2018-2034)
6.4.3 North America Transthyretin Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Transthyretin Sales by Company
7.1.1 Europe Transthyretin Sales Quantity by Company (2018-2023)
7.1.2 Europe Transthyretin Revenue by Company (2018-2023)
7.2 Europe Transthyretin Market Size by Type
7.2.1 Europe Transthyretin Sales Quantity by Type (2018-2034)
7.2.2 Europe Transthyretin Revenue by Type (2018-2034)
7.3 Europe Transthyretin Market Size by Application
7.3.1 Europe Transthyretin Sales Quantity by Application (2018-2034)
7.3.2 Europe Transthyretin Revenue by Application (2018-2034)
7.4 Europe Transthyretin Market Size by Country
7.4.1 Europe Transthyretin Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Transthyretin Revenue by Country (2018-2034)
7.4.3 Europe Transthyretin Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Transthyretin Sales by Company
8.1.1 China Transthyretin Sales Quantity by Company (2018-2023)
8.1.2 China Transthyretin Revenue by Company (2018-2023)
8.2 China Transthyretin Market Size by Type
8.2.1 China Transthyretin Sales Quantity by Type (2018-2034)
8.2.2 China Transthyretin Revenue by Type (2018-2034)
8.3 China Transthyretin Market Size by Application
8.3.1 China Transthyretin Sales Quantity by Application (2018-2034)
8.3.2 China Transthyretin Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Transthyretin Sales by Company
9.1.1 APAC Transthyretin Sales Quantity by Company (2018-2023)
9.1.2 APAC Transthyretin Revenue by Company (2018-2023)
9.2 APAC Transthyretin Market Size by Type
9.2.1 APAC Transthyretin Sales Quantity by Type (2018-2034)
9.2.2 APAC Transthyretin Revenue by Type (2018-2034)
9.3 APAC Transthyretin Market Size by Application
9.3.1 APAC Transthyretin Sales Quantity by Application (2018-2034)
9.3.2 APAC Transthyretin Revenue by Application (2018-2034)
9.4 APAC Transthyretin Market Size by Region
9.4.1 APAC Transthyretin Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Transthyretin Revenue by Region (2018-2034)
9.4.3 APAC Transthyretin Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Transthyretin Sales by Company
10.1.1 Middle East, Africa and Latin America Transthyretin Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Transthyretin Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Transthyretin Market Size by Type
10.2.1 Middle East, Africa and Latin America Transthyretin Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Transthyretin Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Transthyretin Market Size by Application
10.3.1 Middle East, Africa and Latin America Transthyretin Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Transthyretin Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Transthyretin Market Size by Country
10.4.1 Middle East, Africa and Latin America Transthyretin Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Transthyretin Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Transthyretin Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Company Information
11.1.2 Alnylam Pharmaceuticals Inc Overview
11.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Products and Services
11.1.5 Alnylam Pharmaceuticals Inc Transthyretin SWOT Analysis
11.1.6 Alnylam Pharmaceuticals Inc Recent Developments
11.2 Arcturus Therapeutics Inc
11.2.1 Arcturus Therapeutics Inc Company Information
11.2.2 Arcturus Therapeutics Inc Overview
11.2.3 Arcturus Therapeutics Inc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Arcturus Therapeutics Inc Transthyretin Products and Services
11.2.5 Arcturus Therapeutics Inc Transthyretin SWOT Analysis
11.2.6 Arcturus Therapeutics Inc Recent Developments
11.3 Ionis Pharmaceuticals Inc
11.3.1 Ionis Pharmaceuticals Inc Company Information
11.3.2 Ionis Pharmaceuticals Inc Overview
11.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Ionis Pharmaceuticals Inc Transthyretin Products and Services
11.3.5 Ionis Pharmaceuticals Inc Transthyretin SWOT Analysis
11.3.6 Ionis Pharmaceuticals Inc Recent Developments
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Company Information
11.4.2 Neurimmune Holding AG Overview
11.4.3 Neurimmune Holding AG Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Neurimmune Holding AG Transthyretin Products and Services
11.4.5 Neurimmune Holding AG Transthyretin SWOT Analysis
11.4.6 Neurimmune Holding AG Recent Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Information
11.5.2 Pfizer Inc Overview
11.5.3 Pfizer Inc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Pfizer Inc Transthyretin Products and Services
11.5.5 Pfizer Inc Transthyretin SWOT Analysis
11.5.6 Pfizer Inc Recent Developments
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Company Information
11.6.2 Prothena Corp Plc Overview
11.6.3 Prothena Corp Plc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Prothena Corp Plc Transthyretin Products and Services
11.6.5 Prothena Corp Plc Transthyretin SWOT Analysis
11.6.6 Prothena Corp Plc Recent Developments
11.7 Regeneron Pharmaceuticals Inc
11.7.1 Regeneron Pharmaceuticals Inc Company Information
11.7.2 Regeneron Pharmaceuticals Inc Overview
11.7.3 Regeneron Pharmaceuticals Inc Transthyretin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Regeneron Pharmaceuticals Inc Transthyretin Products and Services
11.7.5 Regeneron Pharmaceuticals Inc Transthyretin SWOT Analysis
11.7.6 Regeneron Pharmaceuticals Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Transthyretin Value Chain Analysis
12.2 Transthyretin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transthyretin Production Mode & Process
12.4 Transthyretin Sales and Marketing
12.4.1 Transthyretin Sales Channels
12.4.2 Transthyretin Distributors
12.5 Transthyretin Customers
13 Market Dynamics
13.1 Transthyretin Industry Trends
13.2 Transthyretin Market Drivers
13.3 Transthyretin Market Challenges
13.4 Transthyretin Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Transthyretin Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AG-10
Table 3. Major Manufacturers of ALN-TTRsc02
Table 4. Major Manufacturers of CRX-1008
Table 5. Major Manufacturers of EDE-1307
Table 6. Major Manufacturers of Inotersen Sodium
Table 7. Major Manufacturers of Others
Table 8. Global Transthyretin Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Transthyretin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Transthyretin Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Transthyretin Revenue Market Share by Region (2018-2023)
Table 12. Global Transthyretin Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Transthyretin Revenue Market Share by Region (2024-2034)
Table 14. Global Transthyretin Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 15. Global Transthyretin Sales by Region (2018-2023) & (K Pcs)
Table 16. Global Transthyretin Sales Market Share by Region (2018-2023)
Table 17. Global Transthyretin Sales by Region (2024-2034) & (K Pcs)
Table 18. Global Transthyretin Sales Market Share by Region (2024-2034)
Table 19. Global Transthyretin Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 20. Global Transthyretin Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global Transthyretin Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Transthyretin Revenue Share by Manufacturers (2018-2023)
Table 23. Global Transthyretin Price by Manufacturers 2018-2023 (USD/Pcs)
Table 24. Global Key Players of Transthyretin, Industry Ranking, 2021 VS 2024
Table 25. Global Transthyretin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Transthyretin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin as of 2024)
Table 27. Global Key Manufacturers of Transthyretin, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Transthyretin, Product Offered and Application
Table 29. Global Key Manufacturers of Transthyretin, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 32. Global Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 33. Global Transthyretin Sales Quantity Share by Type (2018-2023)
Table 34. Global Transthyretin Sales Quantity Share by Type (2024-2034)
Table 35. Global Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Transthyretin Revenue Share by Type (2018-2023)
Table 38. Global Transthyretin Revenue Share by Type (2024-2034)
Table 39. Transthyretin Price by Type (2018-2023) & (USD/Pcs)
Table 40. Global Transthyretin Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 41. Global Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 42. Global Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 43. Global Transthyretin Sales Quantity Share by Application (2018-2023)
Table 44. Global Transthyretin Sales Quantity Share by Application (2024-2034)
Table 45. Global Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Transthyretin Revenue Share by Application (2018-2023)
Table 48. Global Transthyretin Revenue Share by Application (2024-2034)
Table 49. Transthyretin Price by Application (2018-2023) & (USD/Pcs)
Table 50. Global Transthyretin Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 51. North America Transthyretin Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America Transthyretin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 53. North America Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 54. North America Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 55. North America Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 58. North America Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 59. North America Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Transthyretin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America Transthyretin Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America Transthyretin Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Transthyretin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 65. North America Transthyretin Sales Quantity by Country (2024-2034) & (K Pcs)
Table 66. Europe Transthyretin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 67. Europe Transthyretin Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 69. Europe Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 70. Europe Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 73. Europe Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 74. Europe Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Transthyretin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe Transthyretin Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Transthyretin Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Transthyretin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. Europe Transthyretin Sales Quantity by Country (2024-2034) & (K Pcs)
Table 81. China Transthyretin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 82. China Transthyretin Revenue by Company (2018-2023) & (US$ Million)
Table 83. China Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. China Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 85. China Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 86. China Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 88. China Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 89. China Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 90. China Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Transthyretin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 92. APAC Transthyretin Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 94. APAC Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 95. APAC Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 98. APAC Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 99. APAC Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Transthyretin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC Transthyretin Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC Transthyretin Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Transthyretin Sales Quantity by Region (2018-2023) & (K Pcs)
Table 105. APAC Transthyretin Sales Quantity by Region (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America Transthyretin Sales Quantity by Company (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Transthyretin Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Transthyretin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America Transthyretin Sales Quantity by Type (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America Transthyretin Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Transthyretin Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Transthyretin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 113. Middle East, Africa and Latin America Transthyretin Sales Quantity by Application (2024-2034) & (K Pcs)
Table 114. Middle East, Africa and Latin America Transthyretin Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Transthyretin Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Transthyretin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Transthyretin Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Transthyretin Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Transthyretin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 120. Middle East, Africa and Latin America Transthyretin Sales Quantity by Country (2024-2034) & (K Pcs)
Table 121. Alnylam Pharmaceuticals Inc Company Information
Table 122. Alnylam Pharmaceuticals Inc Description and Overview
Table 123. Alnylam Pharmaceuticals Inc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 124. Alnylam Pharmaceuticals Inc Transthyretin Product and Services
Table 125. Alnylam Pharmaceuticals Inc Transthyretin SWOT Analysis
Table 126. Alnylam Pharmaceuticals Inc Recent Developments
Table 127. Arcturus Therapeutics Inc Company Information
Table 128. Arcturus Therapeutics Inc Description and Overview
Table 129. Arcturus Therapeutics Inc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 130. Arcturus Therapeutics Inc Transthyretin Product and Services
Table 131. Arcturus Therapeutics Inc Transthyretin SWOT Analysis
Table 132. Arcturus Therapeutics Inc Recent Developments
Table 133. Ionis Pharmaceuticals Inc Company Information
Table 134. Ionis Pharmaceuticals Inc Description and Overview
Table 135. Ionis Pharmaceuticals Inc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 136. Ionis Pharmaceuticals Inc Transthyretin Product and Services
Table 137. Ionis Pharmaceuticals Inc Transthyretin SWOT Analysis
Table 138. Ionis Pharmaceuticals Inc Recent Developments
Table 139. Neurimmune Holding AG Company Information
Table 140. Neurimmune Holding AG Description and Overview
Table 141. Neurimmune Holding AG Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Neurimmune Holding AG Transthyretin Product and Services
Table 143. Neurimmune Holding AG Transthyretin SWOT Analysis
Table 144. Neurimmune Holding AG Recent Developments
Table 145. Pfizer Inc Company Information
Table 146. Pfizer Inc Description and Overview
Table 147. Pfizer Inc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Pfizer Inc Transthyretin Product and Services
Table 149. Pfizer Inc Transthyretin SWOT Analysis
Table 150. Pfizer Inc Recent Developments
Table 151. Prothena Corp Plc Company Information
Table 152. Prothena Corp Plc Description and Overview
Table 153. Prothena Corp Plc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 154. Prothena Corp Plc Transthyretin Product and Services
Table 155. Prothena Corp Plc Transthyretin SWOT Analysis
Table 156. Prothena Corp Plc Recent Developments
Table 157. Regeneron Pharmaceuticals Inc Company Information
Table 158. Regeneron Pharmaceuticals Inc Description and Overview
Table 159. Regeneron Pharmaceuticals Inc Transthyretin Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 160. Regeneron Pharmaceuticals Inc Transthyretin Product and Services
Table 161. Regeneron Pharmaceuticals Inc Transthyretin SWOT Analysis
Table 162. Regeneron Pharmaceuticals Inc Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Transthyretin Distributors List
Table 166. Transthyretin Customers List
Table 167. Transthyretin Market Trends
Table 168. Transthyretin Market Drivers
Table 169. Transthyretin Market Challenges
Table 170. Transthyretin Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Transthyretin Product Picture
Figure 2. Global Transthyretin Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Transthyretin Market Share by Type in 2024 & 2034
Figure 4. AG-10 Product Picture
Figure 5. ALN-TTRsc02 Product Picture
Figure 6. CRX-1008 Product Picture
Figure 7. EDE-1307 Product Picture
Figure 8. Inotersen Sodium Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transthyretin Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Transthyretin Market Share by Application in 2024 & 2034
Figure 12. Familial Amyloid Neuropathies
Figure 13. Alzheimer's Disease
Figure 14. Cardomyopathy
Figure 15. Neuropathy
Figure 16. Others
Figure 17. Transthyretin Report Years Considered
Figure 18. Global Transthyretin Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Transthyretin Revenue 2018-2034 (US$ Million)
Figure 20. Global Transthyretin Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 21. Global Transthyretin Sales Quantity 2018-2034 (K Pcs)
Figure 22. Global Transthyretin Sales Quantity Market Share by Region (2018-2023)
Figure 23. Global Transthyretin Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Transthyretin Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. North America Transthyretin Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Transthyretin Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. Europe Transthyretin Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Transthyretin Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. China Transthyretin Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Transthyretin Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. APAC Transthyretin Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Transthyretin Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 33. Middle East, Africa and Latin America Transthyretin Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Transthyretin Sales Quantity in 2024
Figure 35. The Top 10 and Top 5 Players Market Share by Transthyretin Revenue in 2024
Figure 36. Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 37. Global Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Transthyretin Revenue Market Share by Type (2018-2034)
Figure 39. Global Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Transthyretin Revenue Market Share by Application (2018-2034)
Figure 41. North America Transthyretin Revenue Market Share by Company in 2024
Figure 42. North America Transthyretin Sales Quantity Market Share by Company in 2024
Figure 43. North America Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Transthyretin Revenue Market Share by Type (2018-2034)
Figure 45. North America Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Transthyretin Revenue Market Share by Application (2018-2034)
Figure 47. North America Transthyretin Revenue Share by Country (2018-2034)
Figure 48. North America Transthyretin Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Transthyretin Sales Quantity Market Share by Company in 2024
Figure 52. Europe Transthyretin Revenue Market Share by Company in 2024
Figure 53. Europe Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Transthyretin Revenue Market Share by Type (2018-2034)
Figure 55. Europe Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Transthyretin Revenue Market Share by Application (2018-2034)
Figure 57. Europe Transthyretin Revenue Share by Country (2018-2034)
Figure 58. Europe Transthyretin Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 60. France Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 64. China Transthyretin Sales Quantity Market Share by Company in 2024
Figure 65. China Transthyretin Revenue Market Share by Company in 2024
Figure 66. China Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Transthyretin Revenue Market Share by Type (2018-2034)
Figure 68. China Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Transthyretin Revenue Market Share by Application (2018-2034)
Figure 70. APAC Transthyretin Sales Quantity Market Share by Company in 2024
Figure 71. APAC Transthyretin Revenue Market Share by Company in 2024
Figure 72. APAC Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Transthyretin Revenue Market Share by Type (2018-2034)
Figure 74. APAC Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Transthyretin Revenue Market Share by Application (2018-2034)
Figure 76. APAC Transthyretin Revenue Share by Region (2018-2034)
Figure 77. APAC Transthyretin Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 82. India Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Transthyretin Sales Quantity Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Transthyretin Revenue Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America Transthyretin Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Transthyretin Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Transthyretin Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Transthyretin Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Transthyretin Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Transthyretin Revenue Share by Country (2018-2034)
Figure 91. Brazil Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Transthyretin Revenue (2018-2034) & (US$ Million)
Figure 96. Transthyretin Value Chain
Figure 97. Transthyretin Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed